About Tempus

Tempus is a technology company that uses AI and machine learning to analyze clinical and molecular data to personalize cancer treatment and improve patient outcomes.

Investment Thesis

Leader in precision medicine with vast clinical data assets

Why We Invested

  • Largest library of clinical and molecular data in oncology

  • AI platform improving cancer treatment outcomes for patients

  • Strong partnerships with major health systems and pharma companies

  • Expanding beyond oncology into cardiology and mental health

Key Metrics

$1.3B
Total Funding
$8B
Latest Valuation
11+
Years Active
1000+
Team Size

Company Details

Legal Name Tempus Labs, Inc.
Industry Healthcare Technology
Sectors Healthcare Technology, Precision Medicine
Stage Late-stage
Founded 2015
Headquarters Chicago, Illinois, USA
Company Size 1000+ employees

Investment Overview

Investment Thesis

Leader in precision medicine with vast clinical data assets

Key Investment Factors

Market Opportunity

Tempus operates in the Healthcare Technology market, which is projected to grow significantly in the coming years.

Competitive Advantage

Proprietary technology and strong market position create significant barriers to entry.

Growth Strategy

Clear path to growth through market expansion, product development, and strategic acquisitions.

Financial Summary

$1.3B
Total Funding
$8B
Latest Valuation
Late-stage
Funding Stage
May 2022
Last Funding

Fund Information

Healthcare Innovation Fund

Open Innovation Fund

Investing in breakthrough healthcare technologies, biotechnology, digital health, and medical devices. This fund targets companies with potential to transform healthcare delivery and patient outcomes.

Invest in Tempus

$8B
Latest Valuation
1
Available Funds
Late-stage
Current Stage
$1.3B
Total Funding

Gain exposure to this high-growth company through our professionally managed funds. Our investment team has conducted extensive due diligence to identify promising opportunities.

Sign In to Invest